What teams build with Biocore

Provide regulatory data to an AI agent by calling the Biocore Slim API and feeding its structured JSON into the agent's retrieval context. Because fields are normalized across eight jurisdictions, the agent receives consistent, citable data instead of inconsistent text scraped from PDFs or agency websites.

Biocore is building a Model Context Protocol server, currently in development, that will let AI assistants query regulatory data in natural language. Until it ships, the Biocore Slim API delivers structured JSON that integrates cleanly into LLM agent and retrieval pipelines today.

Biocore grounds LLM answers by supplying normalized, source-traceable regulatory fields the model can cite directly. Instead of hallucinating from loosely parsed labels, an agent retrieves validated drug-label and safety data through the API, improving answer accuracy and giving each response a verifiable regulatory source.

Build a drug information portal by querying the Biocore API for normalized label fields — indications, dosing, warnings, and contraindications — and rendering them in your interface. Webhooks notify your portal when labels change, so displayed information stays current without manual updates or custom DailyMed ingestion.

Biocore provides an FDA drug label API that normalizes DailyMed SPL data into structured JSON. Rather than parsing raw SPL XML, you query clean fields for any drug and receive consistent label content, with the same schema extending to seven additional jurisdictions beyond the FDA.

Keep drug label data current by subscribing to Biocore webhooks, which fire within hours of any label change, new approval, or safety communication. Your portal updates the affected records automatically, so users always see current prescribing information without scheduled re-scraping or manual review of agency sources.

Monitor FDA label changes automatically by subscribing to Biocore webhooks. When a label changes, Biocore dispatches a structured alert identifying the drug, jurisdiction, and change, usually within hours. This replaces daily manual checks of DailyMed with an event-driven feed your compliance systems can act on immediately.

Yes. Biocore monitors eight jurisdictions — FDA, EMA, PMDA, Health Canada, TGA, MHRA, ANSM, and Swissmedic — and sends unified webhook alerts when any of them publishes a label change, approval, or safety communication, so one integration covers all your regulated markets.

Biocore ingests regulatory updates within 24 hours of publication and dispatches webhook events within hours of detecting a change. Compared with manual monitoring that can lag 24–72 hours, this gives compliance and operations teams a meaningful head start on reviewing and responding to regulatory updates.

Biocore functions as a pharmacovigilance data source, delivering structured adverse reaction and safety data through its API. Safety teams pull machine-readable signals normalized across eight jurisdictions into their monitoring systems, replacing manual aggregation of inconsistently formatted data from multiple regulatory agencies with a single consistent feed.

Get adverse event regulatory data by querying Biocore for structured safety and adverse reaction fields tied to specific drugs. The data is normalized across jurisdictions, so a pharmacovigilance system receives consistent records rather than reconciling varied formats from FDA, EMA, and other agencies individually.

Yes. Biocore supports ongoing safety surveillance by combining structured adverse-event data with webhook notifications for new safety communications. Pharmacovigilance teams receive timely, machine-readable updates across eight jurisdictions, enabling continuous signal monitoring and supporting regulatory reporting obligations without manual collection from individual agency portals.

Track competitor drug approvals by querying Biocore for approval and label data across eight jurisdictions and subscribing to webhooks for new events. Instead of manually watching multiple agency sites, strategy teams receive structured, timely notifications when competitors gain approvals or update labels in any covered market.

Yes. Biocore normalizes EMA approval and EPAR data into structured fields you can query programmatically, and webhooks notify you of new European approvals as they occur. This lets commercial and strategy teams monitor EU competitive activity through an API rather than manually reviewing EMA publications.

Biocore supports competitive intelligence by delivering normalized approval, label, and safety data across eight jurisdictions through one API. Teams build dashboards and alerts on competitor activity using consistent structured data, replacing slow manual monitoring of fragmented agency sources with a programmatic, multi-market intelligence feed.

Biocore serves as a formulary data source by delivering normalized drug records with standard identifiers such as NDC, RxNorm, and UNII. Health IT and payer teams reconcile products reliably across systems and ground formulary decisions in current, structured regulatory and label data through a single API.

Get drug formulary regulatory data by querying Biocore for normalized label, identifier, and regulatory fields per product. Because records carry NDC, RxNorm, and UNII identifiers, formulary systems match drugs accurately and stay current as labels and approvals change across the eight jurisdictions Biocore covers.

Biocore helps reconcile drug identifiers by attaching NDC, RxNorm/RxCUI, and UNII codes to its normalized records. Formulary and payer systems use these standard identifiers to match products across data sources accurately, avoiding the mismatches that arise when relying on brand or generic names alone.